|
"hsu ch"的相關文件
顯示項目 336-345 / 418 (共42頁)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2005-07 |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment.
|
Yang, CH; Chen, MC; Cheng, AL; Hsu, CH; Kun-Huei, Yeh; Yu, YC; Whang-Peng, J; Yang, PC. |
| 國立臺灣大學 |
2005-07 |
Structural and DNA-binding Studies on the Bovine Antimicrobial Peptide, Indolicidin: Evidence for Multiple Conformations Involved in Binding to Membranes and DNA.
|
Hsu, CH; Chen, C; Jou, ML; Lee, AY; Lin, YC; Yu, YP; Huang, SH.; Wu, WT |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
| 國立臺灣大學 |
2005-04 |
Relationship of temperamental characteristics to development in very low birth weight infants
|
Tsou, KS; Tsou, KI; Jeng, SF; Hsu, CH; Fang, LJ. |
| 國家衛生研究院 |
2005-03-28 |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Yang, CH; Cheng, AL |
| 國家衛生研究院 |
2005-03 |
Phosphorylation of cytidine, deoxycytidine, and their analog monophosphates by human UMP/CMP kinase is differentially regulated by ATP and magnesium
|
Hsu, CH; Liou, JY; Dutschman, GE; Cheng, YC |
| 國立臺灣大學 |
2005-02 |
Surface-enhanced Raman spectroscopy using self-assembled silver nanoparticles on silicon nanotips
|
Chattopadhyay S; Lo HC; Hsu CH; Chen LC; Chen KH |
| 國家衛生研究院 |
2005 |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Yang, CH; Chen, MC; Cheng, AL; Hsu, CH; Yeh, KH; Yu, YC; Whang-Peng, J; Yang, PC |
| 國家衛生研究院 |
2005 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL |
顯示項目 336-345 / 418 (共42頁)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
每頁顯示[10|25|50]項目
|
